Direct comparison of administration routes for aav8-mediated ocular gene therapy

Current Eye Research

Volumn 38, Issue 5, 2013, Pages 569-577

  Igarashi, Tsutomu ^a   Miyake, Koichi ^a   Asakawa, Nagisa ^a   Miyake, Noriko ^a   Shimada, Takashi ^a   Takahashi, Hiroshi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

AAV vector; Damage; Eye disease; Gene therapy; Intravitreal; IVIS; Subretinal; Type 8

Indexed keywords

ADENO ASSOCIATED VIRUS TYPE 8 VECTOR; ENHANCED GREEN FLUORESCENT PROTEIN; LUCIFERASE; PARVOVIRUS VECTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ELECTRORETINOGRAPHY; HISTOPATHOLOGY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PHOTORECEPTOR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA; VIRAL GENE THERAPY;

ANIMALS; DEPENDOVIRUS; ELECTRORETINOGRAPHY; EYE DISEASES; GENETIC THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; INTRAVITREAL INJECTIONS; LUCIFERASES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PHOTORECEPTOR CELLS, VERTEBRATE; RANDOM ALLOCATION; SUBRETINAL FLUID; TRANSDUCTION, GENETIC; VITREOUS BODY;

EID: 84875894021     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2013.779720     Document Type: Article

References (26)

1. Bainbridge JW, Smith AJ, Barker SS, Robbie S, Henderson R, Balaggan K, et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med 2008;358:2231-2239.
2. Hauswirth WW, Aleman TS, Kaushal S, Cideciyan AV, Schwartz SB, Wang L, et al. Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: Short-term results of a phase I trial. Hum Gene Ther 2008;19:979-990.
3. Maguire AM, Simonelli F, Pierce EA, Pugh EN Jr, Mingozzi F, Bennicelli J, et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med 2008;358: 2240-2248.
4. Lebherz C, Maguire A, Tang W, Bennett J, Wilson JM. Novel AAV serotypes for improved ocular gene transfer. J Gene Med 2008;10:375-382.
5. Igarashi T, Miyake K, Masuda I, Takahashi H, Shimada T. Adeno-associated vector (type 8)-mediated expression of soluble Flt-1 efficiently inhibits neovascularization in a murine choroidal neovascularization model. Hum Gene Ther 2010;21:631-637.
6. Auricchio A, Kobinger G, Anand V, Hildinger M, O'Connor E, Maguire AM, et al. Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: The retina as a model. Hum Mol Genet 2001;10:3075-3081.
7. Igarashi T, Miyake K, Hayakawa J, Kawabata K, Ishizaki M, Takahashi H, Shimada T. Apoptotic cell death and regeneration in the newborn retina after irradiation prior to bone marrow transplantation. Curr Eye Res 2007;32: 543-553.
8. Takahashi H, Kanesaki H, Igarashi T, Kameya S, Yamaki K, Mizota A, et al. Reactive gliosis of astrocytes and Müller glial cells in retina of POMGnT1-deficient mice. Mol Cell Neurosci 2011;47:119-130.
9. Sakurai K, Akiyama H, Shimoda Y, Yoshida I, Kurabayashi M, Kishi S, et al. Effect of intravitreal injection of high-dose bevacizumab in monkey eyes. Invest Ophthalmol Vis Sci 2009;50:4905-4916.
10. Chang HH, Lin DP, Chen YS, Liu HJ, Lin W, Tsao ZJ, et al. Intravitreal homocysteine-thiolactone injection leads to the degeneration of multiple retinal cells, including photoreceptors. Mol Vis 2011;17:1946-1956.
11. Raymond ID, Vila A, Huynh UC, Brecha NC. Cyan fluorescent protein expression in ganglion and amacrine cells in a thy1-CFP transgenic mouse retina. Mol Vis 2008; 25:1559-1574.
12. Laird DW, Molday RS. Evidence against the role of rhodopsin in rod outer segment binding to RPE cells. Invest Ophthalmol Vis Sci 1988;29:419-428.
13. Shahar J, Zemel E, Perlman I, Loewenstein A. Physiological and toxicological effects of cefuroxime on the albino rabbit retina. Invest Ophthalmol Vis Sci 2012;53:906-914.
14. Rebuffat A, Harding CO, Ding Z, Thony B. Comparison of adeno-associated virus pseudotype 1, 2, and 8 vectors administered by intramuscular injection in the treatment of murine phenylketonuria. Hum Gene Ther 2010;21:463-477.
15. Cunha-Vaz J. The blood-ocular barriers. Surv Ophthalmol 1979;23:279-296.
16. Bennett J, Maguire AM. Gene therapy for ocular disease. Mol Ther 2000;1:501-505.
17. Dejneka NS, Rex TS, Bennett J. Gene therapy and animal models for retinal disease. Dev Ophthalmol 2003;37: 188-198.
18. Guérin CJ, Lewis GP, Fisher SK, Anderson DH. Recovery of photoreceptor outer segment length and analysis of membrane assembly rates in regenerating primate photoreceptor outer segments. Invest Ophthalmol Vis Sci 1993; 34:175-183.
19. Kolesnikov AV, Fan J, Crouch RK, Kefalov VJ. Age-related deterioration of rod vision in mice. J Neurosci 2010;30: 11222-11231.
20. Birch DG, Hood DC, Locke KG, Hoffman DR, Tzekov RT. Quantitative electroretinogram measures of phototransduction in cone and rod photoreceptors: Normal aging, progression with disease, and test-retest variability. Arch Ophthalmol 2002;120:1045-1051.
21. Li C, Cheng M, Yang H, Peachey NS, Naash MI. Agerelated changes in the mouse outer retina. Optom Vis Sci 2001;78:425-430.
22. Entezari M, Ahmadieh H, Dehghan MH, Ramezani A, Bassirnia N, Anissian A. Posterior sub-tenon triamcinolone for refractory diabetic macular edema: A randomized clinical trial. Eur J Ophthalmol 2005;15:746-750.
23. Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 2011;364: 1897-1908.
24. Fisher SK, Lewis GP, Linberg KA, Verardo MR. Cellular remodeling in mammalian retina: Results from studies of experimental retinal detachment. Prog Retin Eye Res 2005; 24:395-431.
25. Petrs-Silva H, Dinculescu A, Li Q, Min S, Min SH, Chiodo V, et al. High-efficiency Transduction of the Mouse Retina by Tyrosine-mutant AAV Serotype Vectors. Mole Ther 2009;17:463-471.
26. Gaudreault J, Fei D, Beyer JC, Ryan A, Ryan A, Rangell L, et al. Pharmacokinetics and retinal distribution of ranibizumab, a humanized antibody fragment directed against VEGF-A, following intravitreal administration in rabbits. Retina 2007;27:1260-1266.